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The major targets for cytotoxic lymphocytes (CL's) in mouse are determined by 
genes  of the  H-2  complex.  These  H-2  loci,  alleles  of which  are  important  in 
determining histocompatibility antigens, can be divided into two groups, geneti- 
cally and functionally distinct. The Hld (histocompatibility LD) loci differences 
lead  to  strong  lymphocyte proliferative  responses  in  MLC  and  graft-vs.-host 
(GvH)  reactions; Hsd (histocompatibility SD)  loci (H-2K and H-2D) differences 
usually  lead  to a  relatively weak  MLC  or  GvH  response  (1-5).  Lymphocytes 
activated in MLC against allogeneic cells differing by both H-2 lymphocyte-de- 
fined (LD) and serologically-defined (SD)  components develop cytotoxic poten- 
tial against target cells carrying those same foreign antigens. This cytotoxic test 
is referred to as cell-mediated lympholysis (CML). Whereas LD differences are 
of prime importance in leading to a lymphocyte proliferative response in MLC, 
the  SD antigens, or the phenotypic product of genes very closely linked to the 
SD alleles, serve as the best targets in CML (6-8). We shall refer to these targets 
as SD antigens. 
While LD differences on the sensitizing (stimulating) cells in MLC facilitate 
the  development of cytotoxic reactions  against  the  SD  antigens,  these  deter- 
minants alone lead to only weak cytotoxicity in CML (7,  8, fbotnote 1). At least 
two possibilities  can be  offered to explain this observation:  (a)  LD differences 
alone  in  MLC  do  lead  to  generation  of cytotoxic lymphocytes but  these  LD 
differences do  not  serve  as  adequate targets  in CML; (b)  proliferation due  to 
LD  differences alone does not lead to the formation of effective CL's; the SD 
antigenic differences during the MLC phase facilitate the development of' strong 
cytotoxic activity and act also as the specific target in CML. 
The mechanisms by which sensitized thymus-derived (T) lymphocytes mediate 
cytotoxicity against target cells remains largely obscure. The present day concept 
suggests that specificity of cytotoxic effect is due to receptors on the surface of the 
T-effector lymphocytes which  recognize target cell antigens and thereby allow 
specific cell-cell contact. Once the target and effector cells are in proximity, target 
cell  destruction  is  mediated  nonspecifically. Forman and  MSller recently de- 
scribed such nonspecific target cell destruction (9). They demonstrated that lym- 
phocytes sensitized to alloantigens in MLC are cytotoxic not only to target cells 
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carrying  those  same  antigens,  but  even  to  isogeneic  (self)  targets  when  phyto- 
hemagglutinin  (PHA)  is added to the  mixture  of sensitized  cells and target cells 
during the  cytotoxicity assay (PHA-dependent  cytotoxicity).  To the extent  that 
PHA-dependent  cytotoxicity can be used as a  model for assessing the presence of 
CL's in  CML,  we have  used  this  system  to determine  whether  proliferative  re- 
sponses  to  LD  antigens  alone  can  "generate"  cytotoxic  cells.  Furthermore  we 
have used,  as target  cells,  normal lymphocytes which bear LD antigens  to ascer- 
tain whether the LD products on these cells can serve as targets in CML. 
Materials and Methods 
Mice used in these studies were raised in our own colony; breeding pairs were obtained from J. Stimpf- 
ling, J. Klein, and Jackson Laboratories,  Bar Harbor, Maine. H-2 differences in the strains used have 
been discussed  previously  (1, 8, 10,  11). 
A modification of the MLC technique of Widmer (12) and Phillips (13) is used to generate cytotoxic 
effector lymphocytes. Briefly, 40  ×  106 responding  spleen  cells and 40  ×  10 ~ mitomycin C-treated 
stimulating spleen cells are suspended  in 20 ml of RPMI-1640 containing 5% inactivated (56°C for 30 
min) human pooled plasma and cultured in Falcon tissue culture flasks (no. 3012, Falcon Plastics, Div. 
of BioQuest,  Oxnard,  Calif.) (in a vertical  position} in a humidified  atmosphere of 5% CO2 in air. 
After 5 days of incubation  MLC activation is measured by tritiated thymidine uptake and cell-medi- 
ated lympholysis on sodium chromate (5,Cr)_labeled target cells as previously described (7). Lympho- 
cytes used for target cells are either (a) PHA-stimulated lymph node cells (14) or (b} fresh lymph node 
cells,  i.e., lymph nodes removed from normal animals on the day of CML assay.  PHA-dependent 
cytotoxicity differs from the above in that PHA-M (Difco Laboratories,  Detroit,  Mich.) is added to a 
final concentration of 250 #g/ml to the mixture of effector and target cells during the 3 h incubation  for 
the assay of lympholysis;  this  should  not be confused with the normal CML assay  in which target 
cells are in some cases stimulated with PHA for 3 days before labeling with  5~Cr. 
Results 
Results  of two of the six experiments  performed are shown in Tables I and II. In 
Table I are given results with PHA-stimulated blast cells as target cells;  in Table 
II, fresh  lymphocytes are  used.  In each  table  MLC  results  are  given using cells 
from strains  differing by H-2 LD and SD factors and MLC  mixtures differing by 
LD factors alone. The cytotoxic assay is carried out either as in normal CML tests 
or in the  presence  of PHA  (columns  1 and 2,  respectively,  under  "percent  cyto- 
toxicity"). 
Cultures activated with cells which differ for both LD and SD components gen- 
erate  CL's active  against  the  specific  target.  In spite  of significant  and  similar 
MLC activation,  combinations which differ only by LD show little  if any lysis of 
specific "targets"  [AQR or B10.T(6R)] or of unrelated targets bearing LD and SD 
differences  from the sensitizing  cells  in CML. 
The addition  of PHA  to the  cultures  during  the  3  h  incubation  to determine 
PHA dependent cytotoxicity has different effects depending on the genetic differ- 
ences existing during the MLC activation phase in the experiment:  LD ÷  SD-acti- 
vated cultures generate greater cytotoxic activity against target cells syngeneic to 
the effector cell than when the MLC is activated by LD differences alone, despite 
equivalent levels of proliferative response.  Cultures activated by LD only showed 1412  ALTER  AND  BACH  BRIEF  DEFINITIVE  REPORT 
TABLE I 
PHA-Dependent Cytotoxicity  with PHA-Blast Lymphocytes as Targets 
MLC*  Sensitization of effectors$  Target 
% Cytotoxicity ~= SD II 
No PHA  PHA added 
added during  duringCML 
CML assay  assay 
LD + SD 
19,819 ± 439  BI0.T (6R) + C57BL/10m§ 
13,303 ±  1,075  AQR  + C57BL/10m 
LD 
12,205 ± 604  B10.T(6R)  + AQRm 
14,771 ± 756  AQR + BI0.T(6R)m 
AQR  2.3 ± 2.4  36.3 ± 3.6 
B10.T (6R)  -8.0 ±  1.7  31.8 ± 4.7 
C57BL/10  68.2 ± 4.1  77.9 ± 3.5 
AQR  0.6 ± 0.8  40.1 ± 0.9 
B10.T(6R)  -7.1 ±  1.7  36.8 ± 2.6 
C57BL/10  71.8 ± 4.4  68.9 ± 4.0 
AQR  -4.4 ± 1.6  1.7 ±  1.2 
B10.T(6R)  -14.7 ± 1.7  -3.1 ±  1.7 
C57BL/10  -11.4 ± 3.6  -1.6 ± 5.4 
AQR  -4.9  ±  1.8  5.4 ± 2.4 
B10.T(6R)  -9.5 ±  1.7  2.8 ± 2.5 
C57BL/10  -11.2 ± 3.8  1.4 ± 5.1 
* Mean cpm of triplicate values ± SD; control values are B10.T(6R)  + B10.T(6R)m  -  761 ± 86; AQR 
+  AQRm  =  1,577  ±  47. 
We refer to the four regions of the MHC as K, I, S, D. The loci, alleles of which determine the SD 
antigens are in the K and D regions; the strong LD locus appears to be in the I region. AQR = qkdd; 
B10.T(6R)  -  qqqd; C57BL/10  -  bbbb. 
§ Reciprocal combinations (not shown} were also done with a comparable pattern of results. 
II Percent cytotoxicity is calculated 
ER  SSR 
× 100 
MR  SSR 
where experimental release (ER) represents mean counts per minute (cpm) released from ~lCr labeled 
target  cells  incubated  with  effectors sensitized to  either  LD  or  LD  +  SD  differences; specific 
spontaneous release (SSR) is the mean cpm released from the target when incubated with cultured 
cells syngeneic to the target, e.g. AQR +  AQRJAQR target; maximum release (MR} represents the 
mean cpm released from target cells after rapid freeze-thaw treatmenL Target AQR, MR = 2063 :e 
5.6,  SSR -  570 ±  9.5,  SSR (PHA added during CML assay) = 355 ±  13.4 Target B10.T(6R), MR = 
2,967  ±  162.3,  SSR  -  818  ±  21.0,  SSR  (PHA  added during  CML  assay)  =  571  ±  28.5  Target 
C57BL/10,  MR  -  2,582  :L 66.0,  SSR  -  823  ±  52.5,  SSR (PHA added during CML assay)  =  549  ± 
104.9. 
only a  marginal  increase in percent  cytotoxicity  in the presence of added  PHA  in 
all experiments  except one, in which the addition  of PHA  during the cytotoxicity 
assay led to significant levels of lysis. In that  one experiment,  the percent  lysis in 
PHA-dependent  cytotoxicity after activation  by LD and  SD differences remained 
significantly  higher  in  every  case  (range  22.2%-55.7%)  than  after  activation  by 
LD  differences  alone  (range  8.1%-29.8%).  (Mice  used  in  this  experiment  had 
been  vaccinated  for ectromelia  due to an outbreak  in another  colony on our cam- 
pus;  whether  this is related  to the enhanced  PHA-dependent  cytotoxicity seen is 
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TABLE II 
PHA-Dependent  Cytotoxicity with Fresh Lymphocytes as Targets 
1413 
MLC*  Sensitization of effectors$  Target 
% Cytotoxicity ± SDll 
No PHA  PHA added 
added during  duringCML 
CML assay  assay 
LD + SD 
16,145 ± 826  B10.T (6R)  + C57BL/10m§ 
9,391 ± 433  AQR + C57BL/10m 
LD 
10,097 ± 274  B10.T (6R) + AQRm 
8,253 ± 317  AQR + B10.T (6R)m 
AQR  2.1 ± 4.6  37.0 ± 5.7 
B10.T (6R)  -  1.0 ± 4.5  28.4 ± 4.4 
C57BL/10  55.4 ± 5.0  70.5 ± 2.8 
AQR  5.3 ± 3.3  40.0 ± 5.1 
B10.T (6R)  3.4 ± 4.4  37.1 ± 2.9 
C57BL/10  52.0 ± 7.1  59.2 ± 5.9 
AQR  1.4 ± 4.7  10.8 ± 6.7 
B10.T (6R)  -4.4 ± 5.6  5.0 ± 3.9 
C57BL/10  3.1 e  6.2  7.6 ± 5.5 
AQR  0.4 ± 4.6  5.8 ± 4.7 
B10.T (6R)  8.7 ± 4.1  12.4 ± 3.0 
C57BL/10  3.7 ± 4.5  12.6 ± 5.6 
* Mean cpm of triplicate values ±  SD; control values are B10.T (6R)  +  B10.T (6R)m =  1,128 ±  88; 
AQR +  AQRm  -  2,223  ±  64. 
$ We refer to the four regions of the MHC as K, I, S, D. The loci, alleles of which determine the SD 
antigens, are in the K and D regions; the strong LD locus appears to be in the I region. AQR = qkdd; 
B10.T  (6R)  -  qqqd; C57BL/10  -  bbbb. 
§ Reciprocal combinations (not shown) were also done with a  comparable pattern of results. 
II Percent cytotoxicity is calculated 
ER  SSR 
× 100 
MR  SSR 
where  experimental  release  (ER)  represents  mean  epm  released  from  SlCr labeled  target  cells 
incubated with effeetors sensitized to either LD or LD +  SD differences; specific spontaneous release 
(SSR) is the mean epm released from the target when incubated with cultured cells syngeneie to the 
target, e.g. AQR +  AQRm/AQR target; maximum release (MR) represents the mean cpm released 
from target cells after rapid freeze-thaw treatment. Target AQR, MR  =  664  ±  27.1,  SSR -  212  ± 
10.1, SSR (PHA added during CML assay) -  215 ±  19.0 Target B10.T (6R), MR -  689 ±  18.5, SSR = 
239 ±  18.3, SSR (PHA added during CML assay)  =  244  ±  11.0 Target C57BL/10,  MR -  712  ± 314, 
SSR -  239  ±  14.0,  SSR (PHA added during CML assay)  -  233  ±  24.1. 
These  data  further demonstrate  that  if both  SD and LD differences are present 
during the MLC  sensitization  phase, the effector cells generated  are cytotoxic not 
only to specific target  cells in CML  but also to isogeneic and  other target  cells in 
PttA-dependent  cytotoxicity.  However,  with  only  LD  differences  present  dur- 
ing the  MLC  sensitization  procedure  (identity  for the  SD  antigens)  despite  an 
approximately  equivalent  proliferative response  in MLC,  the cells are only mini- 
mally cytotoxic to any target cells. This is true both with target cells stimulated  3 
days previously with PHA  and with fresh target cells. To the extent  that PHA-de- 
pendent  cytotoxicity can be used to argue about  CL formation  in general these re- 1414  ALTER  AND  BACH  BRIEF  DEFINITIVE  REPORT 
sults suggest strongly that SD differences present during MLC sensitization lead 
to the effective generation of CL's. 
Discussion 
We have proposed that the LD-SD collaboration in CML may be explained by 
the  existence of two  populations of lymphocytes: one responsive to LD differ- 
ences and the other to SD differences. The cell population responding to the SD 
differences would function as  the  cytotoxic lymphocytes in  CML (15). If this 
model is correct, one might imagine that the SD responsive cells are also the most 
active in the PHA-dependent cytotoxicity--thus the greater cytotoxicity even on 
isogeneic target cells given an SD difference in the original sensitizing MLC mix- 
ture. If some proportion of the LD responding cells also respond to SD antigens on 
a  given allogeneic stimulating cell, i.e.,  one cell can respond to both LD and SD 
differences, one would have to conclude that the SD stimulus is in some way help- 
ful in promoting differentiation of these cells to cytotoxic lymphocytes. 
We have recently suggested that H-2 LD differences may be able to lead to posi- 
tive CML (8, footnote 1) even though they are not as "strong" in this regard as are 
the SD differences. This would provide further evidence that the differences be- 
tween H-2 LD and SD components are, at least in some respects, of a quantitative 
nature, as we have suggested in the past (8, 16,  17). It would appear to us that the 
seeming relative importance of LD components in the proliferative phase of the 
MLC test and SD antigens in the CML assay support the concept that such quan- 
titative differences may lead to a differential antigenic function of LD and SD in 
the  complex  sequence  of events present  in  the  in vitro response  to allogeneic 
cells. This is the important question biologically. The findings reported here are 
not inconsistent with this. 
Summary 
The  cell-mediated lympholytic capability of mouse  spleen  cells stimulated in 
mixed lymphocyte culture is determined by lymphocyte-defined (LD) and sero- 
logically-defined (SD)  antigenic differences present  during sensitization. Cells 
which are activated by LD differences alone are markedly less effective in caus- 
ing lysis of target cells. This lack of cytotoxicity is shown to be, at least in part, 
due to the inability of LD differences to allow the efficient generation of cytotoxic 
lymphocytes. SD antigens not only serve as good targets for CML but are also 
shown to be  important for the generation of cytotoxic lymphocytes during the 
mixed lymphocyte culture. 
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